MedTrace Logo

Development and Assessment of The Polycystic Liver Disease Questionnaire (PLD-Q).

NCT02173080 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 594

Last updated 2024-09-19

No results posted yet for this study

Summary

This Pilot study will enable development \& assessment of a Polycystic Liver Disease-specific patient reported outcomes questionnaire (PLD-Q). Polycystic liver disease (PLD) is characterized by the formation of numerous cysts in the liver, and can lead to severe symptomatic hepatomegaly. It is common in patients with autosomal dominant polycystic liver disease (ADPLD) and autosomal dominant polycystic kidney disease (ADPKD).

Conditions

  • Polycystic Liver Disease

Interventions

OTHER

PLD-Q

polycystic liver disease questionnaire

Sponsors & Collaborators

Principal Investigators

  • Marie C Hogan · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2024-03-11
Completion
2024-03-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02173080 on ClinicalTrials.gov